{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:44:17Z","timestamp":1793889857982,"version":"4.8.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jgar.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T18:32:49Z","timestamp":1447525969000},"page":"49-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli"],"prefix":"10.1016","volume":"4","author":[{"given":"Fusun","family":"Can","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Kurt-Azap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"\u0130spir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Nurtop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Seref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130layda","family":"Lo\u00e7lar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-319X","authenticated-orcid":false,"given":"Ozge Nur","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda Ceren","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-9235","authenticated-orcid":false,"given":"Onder","family":"Ergonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2015.10.006_bib0080","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","article-title":"Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey","volume":"56","author":"Arslan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0090","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/AAC.01065-13","article-title":"The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0095","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1128\/AAC.03679-14","article-title":"Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012","volume":"58","author":"Olesen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.10.006_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/653932","article-title":"Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.10.006_bib0110","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.01604-13","article-title":"Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-\u03b2-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007\u20132010","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00988-13","article-title":"Complete genome sequence of the epidemic and highly virulent CTX-M-15-producing H30-Rx subclone of Escherichia coli ST131","volume":"1","author":"Andersen","year":"2013","journal-title":"Genome Announc"},{"key":"10.1016\/j.jgar.2015.10.006_bib0120","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/JCM.00984-13","article-title":"Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome","volume":"51","author":"Tchesnokova","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2015.10.006_bib0125","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.jgar.2015.10.006_bib0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/AAC.01025-12","article-title":"Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections","volume":"57","author":"Adams-Sapper","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkt405","article-title":"Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b\/ST131: risk factors and clinical implications","volume":"69","author":"L\u00f3pez-Cerero","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.10.006_bib0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijantimicag.2014.07.016","article-title":"Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital","volume":"44","author":"Lafolie","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2015.10.006_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-\u03b2-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx","volume":"4","author":"Price","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2015.10.006_bib0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651500106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651500106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T14:20:07Z","timestamp":1537194007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651500106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":15,"alternative-id":["S221371651500106X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2015.10.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}